Deep Brain Stimulation(DBS) + Esketamine for depressive disorder, treatment-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Jan 2025: Trial started, NCT06784388
  2. 20 Jan 2025: Trial registered, NCT06784388

The trials

NCT06784388: Personalized DBS Targeting for Treating Depression

State
Under way
Phase
Early Phase 1
People
5 planned
Started
5 Jan 2025
Primary completion
30 Dec 2027
Arms
Depression
Results
None posted
  1. 5 Jan 2025: Trial started
  2. 20 Jan 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.